SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Aron Rosenthal who wrote (5328)7/15/1998 8:27:00 PM
From: Andreas Helke   of 9719
 
Anika doubled in less then 5 months and now got up seriously 5 days in a row. It was seriously overbought and about everyone expected some profit taking. Once the profit taking started there was little reason to buy today. At least one knowledgeable investor on the Yahoo message board expects the rally to continue after testing support at $16.25 For anyone invested or interested in Anika the Yahoo board is a must read. messages.yahoo.com

Take care that you don't confuse GENZ the stock of Genzyme General with GENZL the tracking stock for Genzymes tissue repair business. GENZ is profitable with very reliable revenue growth and probably undervalued. GENZL is not yet profitable. First profits are expected for FY 2000. Those profits should be high enough to make GENZL very seriously undervalued today.

I don't follow ABT closely enough to have any opinion. ARIA is living at the periphery of my watch list. So far I have not yet managed to buy shares. Maybe I should take a closer look again.

Andreas
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext